|
|
|
|
|
|
The latest genomics news from News Medical |
|
|
|
|
|
 | | At the start of the COVID-19 pandemic, information began to trickle in about who was at higher risk of a dangerous outcome from infection. Men. Those over 65. Smokers. Those with obesity. | | | | Readouts of the full DNA of children with cancer at diagnosis have been implemented as the standard of care in a European first. | | | | The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. | | | | Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them closer to genetic switches on the DNA called enhancers. | | | | Refeyn, the company behind pioneering mass photometry technology, announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in the new draft USP general chapter —as a key orthogonal method for characterizing USP's new adeno-associated virus (AAV) reference standards. | | | | Viruses are entirely dependent on their hosts to reproduce. They ransack living cells for parts and energy and hijack the host's cellular machinery to make new copies of themselves. | | | | A major global study tested whether European-derived polygenic risk scores (PGS) for Alzheimer’s disease can predict risk across diverse populations. While PGS performed well in many groups, it was less accurate in individuals of sub-Saharan African and Indian ancestry, highlighting the urgent need for more inclusive genetic data. | |
|
|
|
 | | How would you rate today's newsletter?
| |
|
|
|
 | |
 |
Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now. |
| |
|
|
|
|